FTV | Ticker Profile - Titan Protect

FTV

Fortive

Industrials · Industrial Machinery & Supplies & Components · US

$61.28

Data: 2026-05-15

✓ ETHICAL PASS

NARROW MOAT

HIGH

Data Confidence: 100.0%

Key Metrics

How this company measures up on the fundamentals that matter

Market Cap

$17.9B

Total market value of the company

Trailing P/E

34.59

Premium valuation

Forward P/E

18.27

Based on estimated future earnings — lower means cheaper

Rev Growth

+7.7%

Year-over-year revenue change

Profit Margin

12.8%

How much profit the company keeps from each dollar of revenue

ROE

6.8%

Return on equity — how efficiently it uses shareholder money

Analyst Target

$63.47

+4% from current price — median analyst estimate

Recommendation

HOLD

Consensus view from 15 analysts covering this stock

About Fortive

Fortive Corporation designs, develops, manufactures, and markets products, software, and services in the United States, China, and internationally. It operates through Intelligent Operating Solutions and Advanced Healthcare Solutions segments. The Intelligent Operating Solutions segment provides advanced instrumentation, software, and services, including maintenance, repair, measurement and condition monitoring, facility and asset lifecycle software applications, and connected worker safety and compliance solutions for manufacturing, process industries, healthcare, utilities and power, communications and electronics, and other industries. This segment markets its products and services under the ACCRUENT, FLUKE, GORDIAN, INDUSTRIAL SCIENTIFIC, INTELEX, and SERVICECHANNEL brand names. The Advanced Healthcare Solutions segment provides critical workflow solutions comprising instrument sterilization, instrument tracking, biomedical test tools, radiation detection and safety monitoring, and end-to-end clinical productivity software and solutions under the ASP, CENSIS, FLUKE BIOMEDICAL, LANDAUER, and PROVATION brand names. Fortive Corporation was incorporated in 2015 and is headquartered in Everett, Washington.

https://www.fortive.com

Country: United States Employees: 10,000 Industry: Scientific & Technical Instruments

Ethical Screening

Five compliance checks based on AAOIFI standards — all must pass for ethical clearance

Business Activity

PASS

Core business does not involve prohibited activities

Debt Ratio

28.2% PASS

Debt must be below 33% of total assets

Cash Ratio

0.0% PASS

Interest-bearing cash below 33% of assets

Receivables

9.0% PASS

Receivables below 49% of assets

Revenue Purity

0.0% PASS

Non-compliant revenue below 5% — any excess requires purification

Valuation

Fair Value Est.

$38.63

What our model estimates this business is worth per share

Margin of Safety

-58.6%

Trading above fair value — no margin of safety

Rating

OVERVALUED

Overall assessment combining ethics, valuation, and quality

Percentile

93.2th

Ranks in the top 7% of our 13,571 screened universe

Ethical Score

87.1

Valuation Score

55.0

Quality Score

52.3

Combined

66.7

Trading at $59, 52% above fair value of $39. Passes all ethical screens. Ranks better than 53% of screened stocks.

Quantitative Intelligence

Statistical analysis of price behaviour, risk, and market regime — independent of fundamental data

Regime

MARKDOWN

Price trending down — defensive positioning

Sharpe Ratio

0.285

Positive but modest risk-adjusted returns

Kelly Fraction

0.0192

Marginal edge — very small allocation suggested

Calmar Ratio

0.161

Drawdown risk outweighs the returns — higher risk profile

Annual Return

4.1%

Historical annualised return based on price data

Max Drawdown

-25.4%

Largest peak-to-trough decline — the worst it has been

HMM State

SIDEWAYS

Price consolidating — no clear directional bias

Days in State

How long the current regime has persisted — longer means more stable

Market Data

Trading characteristics and market positioning

Beta

1.01

Moves slightly more than the broader market

52W High

$62.81

2% below the year high

52W Low

$46.34

32% above the year low

Avg Volume

3,184,833

Average daily shares traded — higher means easier to buy and sell

Short Ratio

4.4

Days it would take all short sellers to cover — higher means more crowded

Short % Float

6.0%

Moderate short interest

Div Yield

0.4%

Annual dividend as a percentage of the share price

EPS (TTM)

$1.70

Earnings per share over the last 12 months

Financial Health

Balance sheet strength and cash generation — the foundation of long-term value

Debt/Equity

0.59

Moderate leverage — manageable

Current Ratio

0.71

Below 1 means short-term obligations exceed liquid assets — risk flag

Quick Ratio

0.53

Like current ratio but excludes inventory — stricter test

Gross Margin

63.3%

Revenue left after cost of goods — higher means pricing power

Operating Margin

17.9%

Profit from core operations before interest and tax

Free Cash Flow

$954M

Positive — the business generates more cash than it spends

Revenue (TTM)

$4.2B

Total revenue over the last 12 months

Net Income

$556M

Profitable — the bottom line is positive

Analyst Coverage

Analysts

Target High

$73.00

Target Median

$63.47

Target Low

$51.00

Recent Insider Activity

SEC Form 4 filings — what company insiders are buying and selling

Date	Insider	Title	Shares	Value
2026-05-04	UNDERWOOD PETER C	Officer	47,557	$2,891,941
2026-05-04	UNDERWOOD PETER C	Officer	47,557	$1,375,348
2026-03-26	LASSITER WRIGHT III	Director	4	$257
2026-03-02	DESJOURDY AMEE	Officer	44,650	—
2026-03-02	MULHALL CHRISTOPHER M.	Officer	15,111	—
2026-03-02	SOROYE OLUMIDE	Chief Executive Officer	68,685	—
2026-03-02	UNDERWOOD PETER C	Officer	17,175	—
2026-03-02	OKERSTROM MARK D	Chief Financial Officer	41,210	—
2026-02-24	SOROYE OLUMIDE	Chief Executive Officer	3,759	—
2026-02-24	UNDERWOOD PETER C	Officer	1,383	—

Source: SEC Form 4 filings via public data. View all insider activity at

Insider Intelligence

Explore the Ethical Screener View Track Record

Data sourced from public filings and market feeds. Not financial advice. Updated: 2026-05-15

Before you go